ArticlePulmonary therapy2025

Elexacaftor/Tezacaftor/Ivacaftor for Cystic Fibrosis: Impact on Hospitalizations and Health Care Resource Utilization in a Universal Health Care Setting.

Hans Kristian Råket et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.